Anticoagulants and antiplatelets are medications taken to prevent blood clots and reduce the risk of cardiovascular events. Though both types of medications serve similar purposes, ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

There was no difference in rates of stroke, residual stenosis, or occlusion at 1 year in patients treated with anticoagulants vs antiplatelet agents in the CADISS trial.

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

Oral anticoagulants are superior to antiplatelet therapy for primary stroke prevention in patients with nonvalvular atrial fibrillation, according to a new Cochrane review.

Anticoagulants may come in a pill form or as an injection. Antiplatelets: These medications target platelets, which play a key role in blood clot formation . Antiplatelets usually come in pill form.

The risks to patients of medical or ophthalmic events surrounding cataract surgery are so low that patients need not alter their anticoagulant or antiplatelet use, according to a large study ...

The Scottish Dental Clinical Effectiveness program has provided a series of guidelines for dental patients on anticoagulants and antiplatelet drugs. This program is initiated by the National ...

CannabinoidCannabis A recent review published in The Journal of Clinical Pharmacology summarizes the current literature evaluating the potential risks associated with concomitant use of cannabis ...

Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...

The researchers found that, after adjusting for sociodemographic and clinical characteristics, chronic use of anticoagulants or antiplatelets did not appear to be associated with a reduced risk ...